<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Busse, Gregory</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Thase, Michael E.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Current Issues in Combined Treatment</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-9</style></pages><abstract><style  face="normal" font="default" size="100%">Which is better: psychotherapy, pharmacotherapy, or a combination of the two? This article presents two differing views on this subject from a psychodynamic clinician's perspective. The psychodynamic model is derived from psychoanalysis, an intensive therapy that seeks to explore the unconscious to reveal to the patient the source of their psychiatric symptoms.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>